22nd Annual Osteoporosis: New Insights in Research, Diagnosis, and Clinical Care - 2025

Need Help?

Register Today!

July 31, 2025
Live Stream Conference - Virtual
Course# MEP26001 - Department: Epidemiology and Biostatistics

 

 

Registration Fees

$400 Physicians

$350 Allied Health Professionals

$300 Residents/Fellows

Cancellation Policy

Cancellations received in writing before July 24, 2025 will be refunded, less a $75 administrative fee. No refunds will be made on cancellations received after that date. Please submit your cancellation request at
https://tiny.ucsf.edu/cmehelp

Registration fee discounts are available for Kaiser and UCSF CCMBM faculty. Please contact Lucy Wu at [email protected] for more information.

Overview

Now in its 22nd year, and presented by the Department of Epidemiology and Biostatistics of the University of California, San Francisco School of Medicine, this 1-day virtual course features an expert faculty that will discuss the epidemiology, pathophysiology, diagnosis, and treatment of osteoporosis. The course will critically review current treatment options. There will be an emphasis on recent developments and current controversies in the etiology, diagnosis, and management of osteoporosis. Additional special topics this year include exercise for fall and fracture prevention, nutrition and skeletal health, and the approach to the premenopausal woman with low bone mass or skeletal fragility.

TARGET AUDIENCE
The course will provide an update on current recommendations about screening and treatment of osteoporosis for health care providers working with osteoporosis patients. It will also benefit researchers, technologists, and pharmaceutical or device company professionals who would find additional scientific background in the disease helpful. No prior clinical or scientific training in osteoporosis is required.

 

Live Stream Meeting 
This course will be offered as a virtual conference. Login instructions along with the digital syllabus will be shared with the attendees a week before the meeting. Included in your registration fee is access to the course recordings on demand after the conference and for 30 days after the course. You must tune in to the live conference (in person or remotely) to claim CME.

Objectives

  • Screen for and diagnose osteoporosis according to the latest evidence-based standards of care;
  • Interpret dual-energy X-ray absorptiometry (DXA) bone density scans and avoid common DXA pitfalls;
  • Provide appropriate pharmacological treatment for osteoporosis, including antiresorptive and anabolic therapies;
  • Assess the benefits and risks of continuing long-term antiresorptive osteoporosis therapy and determine optimal treatment duration;
  • Recommend physical activity to optimize bone health and to help patients with skeletal fragility move safely;
  • Provide evidence-based nutritional guidance for healthy bones;
  • Evaluate and treat, when appropriate, the premenopausal woman with low bone mass or skeletal fragility

Accreditation

Jointly Accredited Provider with Commendation Logo

In support of improving patient care, the University of California, San Francisco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

UCSF designates this live activity for a maximum of 7.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Course Outline

All Times Listed are Pacific Time

Thursday, July 31, 2025 
SCREENING AND DIAGNOSIS 
8:00 AM Zoom Registration and login, housekeeping, overview 
8:10GOsteoporosis Screening and Diagnosis: BMD, FRAX and Assessment of Secondary OsteoporosisSteven T. Harris, MD, FACP, FASBMR
8:50 Q&A 
ANTIRESORPTIVE TREATMENT 
9:00GBisphosphonate Efficacy, Duration, and Drug Holidays: Maximize Benefits and Minimize RiskDennis M. Black, PhD
9:30 Q&A 
9:40GLong-Term Treatment With and Following DenosumabKarin Y. Wu, MD 
10:10 Q&A 
10:20 Break  
ANABOLIC TREATMENT 
10:35GAnabolic and Mixed Anabolic/Antiresorptive Agents: When, and How, and In Whom Use ThemKelly Wentworth, MD
11:05 Q&A 
11:15GLong-Term Monitoring and Management of Bone HealthAnne L. Schafer, MD
11:45 Q&A with the Panel of Morning SpeakersKelly Wentworth, MD
Anne L. Schafer, MD
Karin Y. Wu, MD
Dennis M. Black, PhD
Steven T. Harris, MD, FACP, FASBMR 
Deborah E. Sellmeyer, MD (facilitator)
12:20 PM Lunch Break (Zoom Livestream Closed During This Time)  
SPECIAL TOPICS IN OSTEOPOROSIS 
1:20 PMGNutrition and Skeletal HealthDeborah E. Sellmeyer, MD
1:50 Q&A 
2:00GExercise for Fall and Fracture PreventionLora Giangregorio, PhD
2:30 Q&A 
2:40 DXA Interpretation and PitfallsDeborah E. Sellmeyer, MD
3:10 Q&A 
3:20 Break 
3:35GApproach to the Premenopausal Woman with Low Bone Mass or Skeletal FragilityYumie Rhee, MD
4:05 Q&A 
4:15GClinical Roundtable: Q&A with a Panel of PhysiciansSteven T. Harris, MD, FACP, FASBMR 
Deborah E. Sellmeyer, MD
Karin Y. Wu, MD
Tiffany Y. Kim, MD
Anne L. Schafer, MD (facilitator)  
5:00 Adjourn 

Course Chairs

Dennis M. Black, PhD
Professor of Epidemiology and Biostatistics

Anne L. Schafer, MD
Professor of Medicine and of Epidemiology & Biostatistics, UCSF;
Endocrine Research Unit, San Francisco VA Medical Center

 

 

Faculty

(University of California, San Francisco unless indicated)

UCSF Faculty

Steven T. Harris, MD, FACP, FASBMR
Tiffany Y. Kim, MD
Kelly Wentworth, MD
Karin Y. Wu, MD 

Visiting Faculty

Lora Giangregorio, PhD
Yumie Rhee, MD, PhD 
Deborah Sellmeyer, MD